Last reviewed · How we verify
NCT03966001
Cesarean Scar Defect Formation After First Cesarean Section.
trial testing Transvaginal sonography at six months after cesarean section in Cesarean Section Complications in 250 participants. Status unknown.
1 June 2020
Quick facts
| Lead sponsor | Uludag University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 25 June 2019 |
| Primary completion | 1 June 2020 |
| Estimated completion | 15 December 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Transvaginal sonography at six months after cesarean section
- Transvaginal sonography at twelve months after cesarean section
Conditions studied
- Cesarean Section Complications — all drugs for Cesarean Section Complications →
- Cesarean Wound Disruption — all drugs for Cesarean Wound Disruption →
- Cesarean Wound; Dehiscence — all drugs for Cesarean Wound; Dehiscence →
Sponsor
Uludag University
Who can join
Adults 18 to 45, female only, with Cesarean Section Complications or Cesarean Wound Disruption. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective observational study which will monitor how cesarean section in the first pregnancy will develop a cesarean scar defect. Patients with planned cesarean section in their first pregnancy and those with an emergency cesarean section will be monitored for one year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03966001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cesarean Section Complications
Currently open trials in the same condition.
- NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
- NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
- NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting
Other Uludag University trials
Trials by the same sponsor.
- NCT07478601 — Effect of Erector Spinae Plane Block on Postoperative Respiratory Function After Laparoscopic Cholecystectomy · NA · not yet recruiting
- NCT07440615 — Lower-Limb Muscle Mass and Cardiovascular and Muscular Performance in Males and Females · NA · not yet recruiting
- NCT07393620 — Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic Enceph · not yet recruiting
- NCT07350018 — Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome · Phase 4 · not yet recruiting
- NCT07365605 — Lower-Limb Muscle Mass and Balance Performance · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03966001 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uludag University
- Last refreshed: 26 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing